Cancer

Cancer

Evaluation of Feasibility of Response Adapted Stereotactic Ablative Body Radiotherapy in Melanoma

Researchers at the Icon Cancer Foundation have initiated a clinical trial to evaluate the feasibility of response-adapted or response-and-anatomical-adapted Stereotactic Ablative Body Radiotherapy (SABR) in patients with advanced melanoma receiving immunotherapy. The trial, registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) as ACTRN12624001299594, aims to develop a method

Cancer

Breakthrough in Vaccine Development: Engineered Extracellular Vesicles-based Platform for Combined mRNA and Protein Vaccines

A team of researchers from the University of Texas MD Anderson Cancer Center has made a significant discovery in vaccine development by creating a novel, easy-to-execute, and cost-effective engineered extracellular vesicles (EVs)-based combined mRNA and protein vaccine platform (EVX-M+P vaccine). This platform has shown promise in proof-of-concept immunity

Cancer

SWI/SNF Family Mutations in Advanced Non-Small Cell Lung Cancer: Genetic Characteristics and Immune Checkpoint Inhibitors' Therapeutic Implication

Researchers from Sun Yat-sen University in Guangzhou, China, have made significant discoveries regarding the genetic characteristics of SWI/SNF family mutations in Chinese non-small-cell lung cancer (NSCLC) patients. The study, published in ESMO Open, found that approximately 15% of Chinese patients with lung cancer harbor mutations in the SWI/SNF